Utility of the Haemophilia Joint Health Score in study of episodically treated boys with severe haemophilia A and B in Lithuania
S. SAULYTE TRAKYMIENE
Vilnius University Children’s Hospital, Pediatric Hematology/Oncology, Vilnius, Lithuania
Search for more papers by this authorJ. INGERSLEV
Skejby University Hospital, Centre for Haemophilia and Thrombosis, Aarhus N, Denmark
Search for more papers by this authorL. RAGELIENE
Vilnius University, Faculty of Medicine, Vilnius, Lithuania
Search for more papers by this authorS. SAULYTE TRAKYMIENE
Vilnius University Children’s Hospital, Pediatric Hematology/Oncology, Vilnius, Lithuania
Search for more papers by this authorJ. INGERSLEV
Skejby University Hospital, Centre for Haemophilia and Thrombosis, Aarhus N, Denmark
Search for more papers by this authorL. RAGELIENE
Vilnius University, Faculty of Medicine, Vilnius, Lithuania
Search for more papers by this authorAbstract
Summary. Musculoskeletal outcome remains the major hallmark of haemophilia. The purpose of the study was to assess joint status using a new musculoskeletal assessment tool in children with haemophilia and describe the development of haemophilic arthropathy during childhood and puberty focussing on the age of remarkable changes. The prospective study involved Lithuanian patients aged 4–17 years with severe haemophilia A and B, no signs of inhibitors and treatment on-demand. Patients were subdivided into two groups according to actual age. Group I patients were 4–9 years and group II patients 10–17 years of age. The musculoskeletal status was measured using the Haemophilia Joint Health Score (HJHS). We report on 20 patients with a mean age of 11.5 years (SD 4.3, range 4–17.2 years). The mean HJHS score was 24.5 (SD 14.5, range 5–50). The most affected joints were ankles, followed by knees and elbows. Mean HJHS score in age group I (n = 7) was 11.6 (SD 6.5); in group II (n = 13) the score was significantly higher – mean 31.5 (SD 12.8) (P = 0.0002). Ankles, knees and elbows were significantly more impaired based on the HJHS scores in older patients as compared with younger ones. The HJHS appears to be a useful tool in evaluating musculoskeletal outcome of patients receiving treatment on-demand. Children ≥10 years of age had significantly higher HJHS scores as a sign of progressing haemophilic arthropathy. We conclude that the most aggravating development of haemophilic joint damage seems to occur from the age of 10 and onwards.
References
- 1 Hilgartner MW. Current treatment of hemophilic arthropathy. Curr Opin Pediatr 2002; 14: 46–9.
- 2 Blanchette VS, Manco-Johnson M, Santagostino E, Ljung R. Optimizing factor prophylaxis for the haemophilia population: where do we stand? Haemophilia 2004; 10(Suppl. 4): 97–104.
- 3 Feldman BM, Funk S, Lundin B, Doria AS, Ljung R, Blanchette V. Musculoskeletal measurement tools from the International Prophylaxis Study Group (IPSG). Haemophilia 2008; 14(Suppl. 3): 162–9.
- 4 Hilliard P, Funk S, Zourikian N et al. Hemophilia joint health score reliability study. Haemophilia 2006; 12: 518–25.
- 5 Klukowska A, Czyrny Z, Laguna P, Brzewski M, Serafin-Krol MA, Rokicka-Milewska R. Correlation between clinical, radiological and ultrasonographical image of knee joints in children with haemophilia. Haemophilia 2001; 7: 286–92.
- 6 Lafeber FP, Miossec P, Valentino LA. Physiopathology of haemophilic arthropathy. Haemophilia 2008; 14(Suppl. 4): 3–9.
- 7 Gilbert MS. Musculoskeletal complications of haemophilia: the joint. Haemophilia 2000; 6(Suppl. 1): 34–7.
- 8 World Federation of Hemophilia. Hemophilia in Pictures Educator’s Guide: World Federation of Hemophilia. 2008; Quebec, Canada.
- 9 Manco-Johnson MJ, Pettersson H, Petrini P et al. Physical therapy and imaging outcome measures in a haemophilia population treated with factor prophylaxis: current status and future directions. Haemophilia 2004; 10(Suppl. 4): 88–93.
- 10 Mancuso ME, Graca L, Auerswald G, Santagostino E. Haemophilia care in children – benefits of early prophylaxis for inhibitor prevention. Haemophilia 2009; 15(Suppl. 1): 8–14.
- 11 Roosendaal G, Jansen NWD, Schutgens R, Lafeber FPJG. Haemophilic arthropathy: the importance of the earliest haemarthroses and consequences for treatment. Haemophilia 2008; 14: 4–10.
- 12 Hoots WK, Rodriguez N, Boggio L, Valentino LA. Pathogenesis of haemophilic synovitis: clinical aspects. Haemophilia 2007; 13(Suppl. 3): 4–9.
- 13 Roosendaal G, Tekoppele JM, Vianen ME, Van Den Berg HM, Lafeber FP, Bijlsma JW. Articular cartilage is more susceptible to blood induced damage at young than at old age. J Rheumatol 2000; 27: 1740–4.
- 14 Berntorp E, Astermark J, Bjorkman S et al. Consensus perspectives on prophylactic therapy for haemophilia: summary statement. Haemophilia 2003; 9(Suppl. 1): 1–4.
- 15 Nilsson IM, Hedner U, Ahlberg A. Haemophilia prophylaxis in Sweden. Acta Paediatr Scand 1976; 65: 129–35.
- 16 Aledort LM, Haschmeyer RH, Pettersson H. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group. J Intern Med 1994; 236: 391–9.
- 17
Manco-Johnson MJ,
Funk SM.
Joint evaluation instruments in haemophilia. In: EC Rodriguez-Merchan
ed. The Haemophilic Joints: New Perspectives, 1st edn. Oxford: Blackwell Publishing, 2003: 45–55.
10.1002/9780470986929.ch8 Google Scholar
- 18 Gilbert MS. Prophylaxis: musculoskeletal evaluation. Semin Hematol 1993; 30(3 Suppl. 2): 3–6.
- 19 Pettersson H, Ahlberg A, Nilsson IM. A radiologic classification of hemophilic arthropathy. Clin Orthop Relat Res 1980; 149: 153–9.
- 20 Fischer K, Van Der Bom JG, Mauser-Bunschoten EP et al. The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia. Blood 2002; 99: 2337–41.
- 21 Van Den Berg HM, Fischer K, Mauser-Bunschoten EP et al. Long-term outcome of individualized prophylactic treatment of children with severe haemophilia. Br J Haematol 2001; 112: 561–5.
- 22 Aznar JA, Magallon M, Querol F, Gorina E, Tusell JM. The orthopaedic status of severe haemophiliacs in Spain. Haemophilia 2000; 6: 170–6.
- 23 Nilsson IM, Berntorp E, Lofqvist T, Pettersson H. Twenty-five years’ experience of prophylactic treatment in severe haemophilia A and B. J Intern Med 1992; 232: 25–32.
- 24 Manco-Johnson MJ, Nuss R, Funk S, Murphy J. Joint evaluation instruments for children and adults with haemophilia. Haemophilia 2000; 6: 649–57.
- 25 Hill FG, Ljung R. Third and fourth Workshops of the European Paediatric Network for Haemophilia Management. Haemophilia 2003; 9: 223–8.
- 26 Rodriguez-Merchan EC. Orthopaedic assessment in haemophilia. Haemophilia 2003; 9(Suppl. 1): 65–74. Discussion
- 27 Feldman BM, Babyn P, Doria AS et al. Proceedings of the International Haemophilia Prophylaxis Study Group Meeting, November 2003, Montreal, PQ, Canada. Haemophilia 2005; 11: 58–63.
- 28 Beeton K, De Kleijn P, Hilliard P et al. Recent developments in clinimetric instruments. Haemophilia 2006; 12(Suppl. 3): 102–7.
- 29 Kilcoyne RF, Nuss R. Radiological assessment of haemophilic arthropathy with emphasis on MRI findings. Haemophilia 2003; 9(Suppl. 1): 57–63. Discussion – 4.
- 30 Feldman BF, Funk S, Hillard P et al. The Haemophilia Joint Health Score (HJHS) international validation study. Haemophilia (Abstracts of the XXVIIIth International Congress of the World Federation of Hemophilia). 2008; 14(Suppl. 2): 83.
- 31 Saulyte Trakymiene S, Rageliene L. Optimal treatment for children with haemophilia: a review. Acta Med Lituanica 2009; 16: 3–10.
- 32 Hermann G, Gilbert MS, Abdelwahab IF. Hemophilia: evaluation of musculoskeletal involvement with CT, sonography, and MR imaging. AJR Am J Roentgenol 1992; 158: 119–23.
- 33 Raffini L, Manno C. Modern management of haemophilic arthropathy. Br J Haematol 2007; 136: 777–87.
- 34 Roosendaal G, Jansen NW, Schutgens R, Lafeber FP. Haemophilic arthropathy: the importance of the earliest haemarthroses and consequences for treatment. Haemophilia 2008; 14(Suppl. 6): 4–10.
- 35 Manco-Johnson MJ, Abshire TC, Shapiro AD et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357: 535–44.
- 36 Chen L, Sun J, Wu R et al. Joint health status of Chinese hemophilia children: a pilot study using the Hemophilia Joint Health Assessment Scale (HJHS). Haemophilia 2008; 14(Suppl. 2): 79.
- 37 Engelbert RH, Plantinga M, Van der Net J et al. Aerobic capacity in children with hemophilia. J Pediatr 2008; 152: 833–8. 8 e1.
- 38 Plug I, Van Der Bom JG, Peters M et al. Thirty years of hemophilia treatment in the Netherlands, 1972–2001. Blood 2004; 104: 3494–500.
- 39 Molho P, Rolland N, Lebrun T et al. Epidemiological survey of the orthopaedic status of severe haemophilia A and B patients in France. The French Study Group [email protected]. Haemophilia 2000; 6: 23–32.
- 40 Petrini P, Lindvall N, Egberg N, Blomback M. Prophylaxis with factor concentrates in preventing hemophilic arthropathy. Am J Pediatr Hematol Oncol 1991; 13: 280–7.
- 41 Funk M, Schmidt H, Escuriola-Ettingshausen C et al. Radiological and orthopedic score in pediatric hemophilic patients with early and late prophylaxis. Ann Hematol 1998; 77: 171–4.
- 42 Colvin BT, Astermark J, Fischer K et al. European principles of haemophilia care. Haemophilia 2008; 14: 361–74.
- 43 Ljung RC. Aspects of haemophilia prophylaxis in Sweden. Haemophilia 2002; 8(Suppl. 2): 34–7.
Citing Literature
